Rate My Professor David Durrheim

Durrheim's research focuses on novel infectious disease surveillance methods, control of zoonotic diseases, immunization strategies, measles and rubella elimination, outbreak investigation, and public health responses to epidemics, including COVID-19 and influenza via systems like Flutracking. Key publications include 'Broad benefits of the COVID-19 pandemic response' (Science, 2021), 'Measles and rubella eradication: commitment to a global target is now a matter of urgency' (The Lancet Infectious Diseases, 2025), 'Global Measles Eradication Goal is Urgently Needed' (Nature, 2025), 'Insights from Flutracking: thirteen tips to growing a web-based participatory surveillance system' (Journal of Medical Internet Research, 2017), and 'Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial' (JAMA Cardiology, 2025). He chairs the Western Pacific Regional Measles Elimination Verification Commission since 2012 and Australia's National Polio Elimination Certification Committee since 2013, served on the WHO Strategic Advisory Group of Experts on Immunization (2009-2012), and contributes to editorial boards such as IJID One Health. Awards include Fellowship of the Australian Academy of Health and Medical Sciences (FAAHMS, 2018), Member of the Order of Australia (AM, 2021), Freeman of the City of Lake Macquarie (2024), and James Cook University Outstanding Alumni Award (2011).